-
Orthofix under investigation
Pomerantz law firm is investigating Orthofix, according to an Oct. 3 news release. -
Centinel Spine reaches 250,000 prodisc implants
Centinel Spine has implanted more than 250,000 prodisc devices worldwide since its first implantation in 1990. -
Dr. Tal Davidson joins Augmedics as research and development leader
Augmedics named Tal Davidson, MD, as vice president of research and development, the medtech company said Oct. 3. -
SurGenTec earns FDA nod for new SI joint fusion system
SurGenTec earned FDA clearance for its TiLink-P sacroiliac joint fusion system, the devicemaker said Oct. 3. -
Intracept spine procedure earns coverage from Anthem Blue Cross and Blue Shield
Relievant Medsystems' Intracept spine procedure earned a positive coverage policy from Anthem Blue Cross Blue Shield, the medtech company said Oct. 3. -
Premia Spine gets CMS payment for spinal fusion alternative
Premia Spine earned CMS' New Technology Add-on Payment for the TOPS system, the devicemaker said Oct. 2. -
Johns Hopkins Bayview adding Globus imaging system
Baltimore, Md.-based Johns Hopkins Bayview is adding Globus' Excelsius 3D intraoperative imaging system to its growing fleet of robotic technology, according to a Sept. 27 LinkedIn post. -
Spine medtech earning FDA nods in Q3
Here are eight spine medtech products earning FDA approvals and clearances in the third quarter of 2023: -
Alphatec CEO offloads additional stock
Alphatec's CEO, Patrick Miles, disposed 179,375 company shares for about $12.46 to $13 per share, Seeking Alpha reported Sept. 28. -
Centinel Spine reaches new total disc replacement milestone
Centinel Spine's Prodisc C Vivo and C SK cervical disc implants reached 2,500 U.S. cases, the devicemaker said Sept. 28. -
CTL Amedica earns US Department of Defense contract for spine products
CTL Amedica recently landed electronic catalog government contract approval from the U.S. Defense Logistics Agency. -
Onward's spinal cord stimulator implanted in first patient
Onward's ARC-IM spinal stimulator was implanted in the first human patient, the devicemaker said Sept. 27. -
ZimVie earns FDA nod for cervical disc replacement hybrid study
The FDA gave ZimVie's Mobi-C cervical disc hybrid investigational device exemption, the devicemaker said Sept. 26. -
Smaller devicemakers eye mergers in Q3
Large spine and orthopedic mergers have closed this year, and smaller device companies have sought to get their own slice of the pie during the third quarter. -
Artificial disc market to crack $1B by 2030
The artificial disc replacement market is expexted to surpass $1.3 billion by 2030, according to Vantage Market Research. -
Alphatec CEO sells $2.42M worth of stock on the heels of strong Q2
Patrick Miles, CEO of Alphatec, sold 180,000 shares of the company for about $2.42 million, Seeking Alpha reported Sept. 20. -
Patient-specific spine implant earns another breakthrough device designation
Carlsmed received its second FDA breakthrough device designation for Aprevo, the medtech company said Sept. 20. -
ChoiceSpine earns FDA clearance for cervical spacer system
ChoiceSpine recently received FDA clearance to market its Blackhawk Ti 3D-printed cervical spacer system. -
Neuralink begins recruitment for human trials
Neuralink, Elon Musk's brain chip company, is recruiting for human trials, according to a Sept. 19 post on X, formerly known as Twitter. -
AI spine image analysis platform earns FDA clearance
Medical Metrics' Spine Camp platform earned FDA 510(k) clearance, the medtech company said Sept. 19.
Page 10 of 189